货号:A291759 同义名: Azd7986;INS 1007
AZD7986 is a second generation reversible covalent, potent and selective DPP1 inhibitor potentially for the treatment of chronic obstructive pulmonary disease (COPD) with predicted human PK properties suitable for once daily human dosing.
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Brensocatib acts as an inhibitor of DPP1, exhibiting pIC50 values of 6.85, 7.6, 7.7, 7.8, and 7.8 across various species—human, mouse, rat, dog, and rabbit, respectively. Brensocatib demonstrates stability in the propionaldehyde reactivity assay, maintaining a half-life exceeding 50 hours. When cells are differentiated in the presence of Brensocatib, ranging from 38 pM to 10 μM, a notable reduction in enzyme activity within cell lysates is observed for DPP1 and the three neutrophil serine proteases (NSPs)—NE, Pr3, and CatG. Brensocatib effectively suppresses the activation of these NSPs in a dose-responsive manner, with pIC50 values approximating 7 for each. At a concentration of 10 μM Brensocatib, the activity levels of NE, Pr3, and CatG are significantly diminished, dropping to 4 to 10% of the baseline control[1]. |
Animal study | Brensocatib exhibits commendable stability in plasma, maintaining a half-life of over 10 hours. In vivo, Brensocatib selectively inhibits the activation of NE and Pr3 in a dose-dependent fashion within bone marrow cell lysates, while CatG activation remains unaffected[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.89mL 2.38mL 1.19mL |
23.78mL 4.76mL 2.38mL |
CAS号 | 1802148-05-5 |
分子式 | C23H24N4O4 |
分子量 | 420.461 |
别名 | Azd7986;INS 1007;INS1007, Brensocatib |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(249.73 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |